Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3, reflecting a page version update.
    Difference
    0.0%
    Check dated 2026-03-19T05:25:20.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:20:43.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Updated the Study Details page with revised trial design and outcome measures. Expanded the Locations/Enrollment information.
    Difference
    0.0%
    Check dated 2026-03-04T23:52:15.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior Revision: v3.4.1 notice was removed; the page now reflects the current revision status.
    Difference
    0.2%
    Check dated 2026-02-11T14:15:48.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding with links to cc.nih.gov and opm.gov was added. The release notes show Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.2%
    Check dated 2026-02-04T10:20:22.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Show glossary has been added to the page, and new labels include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' along with a Revision: v3.4.0 note. The corresponding older labels 'Last Update Submitted that met QC Criteria,' 'No FEAR Act data,' and Revision: v3.3.4 have been removed.
    Difference
    0.1%
    Check dated 2026-01-28T05:10:03.000Z thumbnail image

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.